Lexicon Pharmaceuticals to Present at the Leerink Partners Global Healthcare Conference 2025
Lexicon Pharmaceuticals (Nasdaq: LXRX) has announced its upcoming participation in the Leerink Partners Global Healthcare Conference 2025 in Miami. The company's management will engage in a fireside chat scheduled for Wednesday, March 12, at 10:00 a.m. ET. Both the live presentation and a subsequent replay will be made available to interested parties through the Events section of Lexicon's investor relations website at investors.lexpharma.com.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha annunciato la sua prossima partecipazione alla Conferenza Globale sulla Salute di Leerink Partners 2025 a Miami. La direzione dell'azienda parteciperà a una chiacchierata informale programmata per mercoledì 12 marzo, alle 10:00 ET. Sia la presentazione dal vivo che una successiva registrazione saranno rese disponibili agli interessati attraverso la sezione Eventi del sito web delle relazioni con gli investitori di Lexicon all'indirizzo investors.lexpharma.com.
Lexicon Pharmaceuticals (Nasdaq: LXRX) ha anunciado su próxima participación en la Conferencia Global de Salud de Leerink Partners 2025 en Miami. La dirección de la empresa participará en una charla informal programada para miércoles 12 de marzo, a las 10:00 a.m. ET. Tanto la presentación en vivo como una repetición posterior estarán disponibles para las partes interesadas a través de la sección de Eventos del sitio web de relaciones con inversores de Lexicon en investors.lexpharma.com.
Lexicon Pharmaceuticals (Nasdaq: LXRX)는 마이애미에서 열리는 Leerink Partners 글로벌 헬스케어 컨퍼런스 2025에 참여할 것이라고 발표했습니다. 회사 경영진은 3월 12일 수요일 오전 10시 ET에 예정된 대화형 세션에 참여할 예정입니다. 생중계와 이후의 재방송은 Lexicon의 투자자 관계 웹사이트인 investors.lexpharma.com의 이벤트 섹션을 통해 관심 있는 분들에게 제공될 것입니다.
Lexicon Pharmaceuticals (Nasdaq: LXRX) a annoncé sa prochaine participation à la Conférence Mondiale sur la Santé de Leerink Partners 2025 à Miami. La direction de l'entreprise participera à une discussion informelle prévue pour mercredi 12 mars à 10h00 ET. La présentation en direct ainsi qu'une rediffusion ultérieure seront mises à la disposition des parties intéressées via la section Événements du site web des relations avec les investisseurs de Lexicon à l'adresse investors.lexpharma.com.
Lexicon Pharmaceuticals (Nasdaq: LXRX) hat seine bevorstehende Teilnahme an der Leerink Partners Global Healthcare Conference 2025 in Miami angekündigt. Das Management des Unternehmens wird an einem informellen Gespräch teilnehmen, das für Mittwoch, den 12. März, um 10:00 Uhr ET geplant ist. Sowohl die Live-Präsentation als auch eine anschließende Wiederholung werden interessierten Parteien über den Bereich Veranstaltungen auf der Investor-Relations-Website von Lexicon unter investors.lexpharma.com zur Verfügung gestellt.
- None.
- None.
THE WOODLANDS, Texas, March 07, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate in a fireside chat at the Leerink Partners Global Healthcare Conference 2025 in Miami on Wednesday, March 12, at 10:00 a.m. ET.
The live event and a replay of the presentation can be accessed via the Events page of the Company’s website at https://investors.lexpharma.com/.
About Lexicon Pharmaceuticals
Lexicon is a biopharmaceutical company with a mission of pioneering medicines that transform patients’ lives. Through the Genome5000™ program, Lexicon’s unique genomics target discovery platform, Lexicon scientists studied the role and function of nearly 5,000 genes and identified more than 100 protein targets with significant therapeutic potential in a range of diseases. Through the precise targeting of these proteins, Lexicon is pioneering the discovery and development of innovative medicines to safely and effectively treat disease. Lexicon has advanced multiple medicines to market and has a pipeline of promising drug candidates in discovery and clinical and preclinical development in heart failure, neuropathic pain, obesity, cardiology, diabetes and other indications. For additional information, please visit www.lexpharma.com.
For Investor and Media Inquiries:
Lisa DeFrancesco
Lexicon Pharmaceuticals, Inc.
lexinvest@lexpharma.com
FAQ
When is Lexicon Pharmaceuticals (LXRX) presenting at the Leerink Partners Conference 2025?
How can investors access LXRX's Leerink Partners Conference 2025 presentation?
What type of presentation will LXRX deliver at the Leerink Partners Healthcare Conference?
Where is the Leerink Partners Global Healthcare Conference 2025 being held?
